Our study further demonstrates that while HCC cells are growth-inhibited by exogenous TGF-β, they require autocrine TGF-β signaling for survival and malignancy, both of which are dependent on Smad4. The gene discussed is SMAD4; the disease is hepatocellular carcinoma.